01 1Farxiga/Forxiga
02 8Farxiga/Forxiga
03 7Forxiga
04 2Qtern
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 1,959
2019 Revenue in Millions : 1,543
Growth (%) : 27
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 3,000
2020 Revenue in Millions : 1,959
Growth (%) : 53
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 198
2019 Revenue in Millions : 163
Growth (%) : 22
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 274
2020 Revenue in Millions : 190
Growth (%) : 55
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 400
2021 Revenue in Millions : 274
Growth (%) : 46
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 4,381
2021 Revenue in Millions : 3,000
Growth (%) : 46
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 5,963
2022 Revenue in Millions : 4,381
Growth (%) : 36
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 488
2022 Revenue in Millions : 400
Growth (%) : 39
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 0
2014 Revenue in Millions : 492
Growth (%) : New Launch
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 1,074
2016 Revenue in Millions : 835
Growth (%) : 29
LOOKING FOR A SUPPLIER?